CTXR - CIK 0001506251
Citius Pharmaceuticals, Inc. has filed 625 documents with the SEC between 2010 and 2026. The most frequent type is major company event (181 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2021-02-18 | 2021-02-16 |
| Insider trade | 4 | 2021-02-18 | 2021-02-16 |
| Prospectus supplement | 424B5 | 2021-02-18 | - |
| S-3MEF | - | 2021-02-16 | - |
| Major company event | 8-K | 2021-02-16 | 2021-02-16 |
| Passive ownership stake (update) | SC 13G/A | 2021-02-16 | - |
| SEC STAFF LETTER | - | 2021-02-11 | - |
| Quarterly report | 10-Q | 2021-02-11 | 2020-12-31 |
| Major company event | 8-K | 2021-02-09 | 2021-02-09 |
| EFFECT | - | 2021-02-05 | - |
| 424B3 | - | 2021-02-05 | - |
| Company correspondence | CORRESP | 2021-02-03 | - |
| SEC correspondence | UPLOAD | 2021-02-03 | - |
| D | - | 2021-02-01 | - |
| Securities registration | S-3 | 2021-01-29 | - |
| Major company event | 8-K | 2021-01-27 | 2021-01-24 |
| Major company event | 8-K | 2021-01-11 | 2021-01-11 |
| Proxy materials | DEFA14A | 2020-12-21 | - |
| Proxy statement | DEF 14A | 2020-12-21 | 2021-02-09 |
| Annual report | 10-K | 2020-12-16 | 2020-09-30 |
| Major company event | 8-K | 2020-12-09 | 2020-12-09 |
| Major company event | 8-K | 2020-12-08 | 2020-12-08 |
| Major company event | 8-K | 2020-11-30 | 2020-11-30 |
| Major company event | 8-K | 2020-10-26 | 2020-10-25 |
| Major company event | 8-K | 2020-10-09 | 2020-10-06 |
| Insider trade | 4 | 2020-10-09 | 2020-10-06 |
| Insider trade | 4 | 2020-10-09 | 2020-10-06 |
| Insider trade | 4 | 2020-10-09 | 2020-10-06 |
| Insider trade | 4 | 2020-10-09 | 2020-10-06 |
| Insider trade | 4 | 2020-10-09 | 2020-10-06 |
| Insider trade | 4 | 2020-10-09 | 2020-10-06 |
| Insider trade | 4 | 2020-10-09 | 2020-10-06 |
| Insider trade | 4 | 2020-10-09 | 2020-10-06 |
| EFFECT | - | 2020-09-30 | - |
| Major company event | 8-K | 2020-09-29 | 2020-09-29 |
| EFFECT | - | 2020-09-25 | - |
| POS AM | - | 2020-09-25 | - |
| 424B3 | - | 2020-09-25 | - |
| Major company event | 8-K | 2020-09-22 | 2020-09-22 |
| Company correspondence | CORRESP | 2020-09-18 | - |
| SEC correspondence | UPLOAD | 2020-09-18 | - |
| Major company event | 8-K | 2020-09-15 | 2020-09-15 |
| Securities registration | S-3 | 2020-09-11 | - |
| Major company event | 8-K | 2020-08-26 | 2020-08-26 |
| Major company event | 8-K | 2020-08-26 | 2020-08-26 |
| Quarterly report | 10-Q | 2020-08-14 | 2020-06-30 |
| Major company event | 8-K | 2020-08-10 | 2020-08-05 |
| Prospectus supplement | 424B5 | 2020-08-07 | - |
| Free writing prospectus | FWP | 2020-08-06 | - |
| Free writing prospectus | FWP | 2020-08-05 | - |